CORE--PHARMACOLOGY

核心--药理学

• 批准号: 6445495
• 负责人: MATTHEW M AMES
• 金额: $ 7.23万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-04-04 至 2002-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6445495
• 关键词: biomedical facility; drug metabolism; neoplasm /cancer; neoplasm /cancer pharmacology; oncology; pharmacokinetics

The Pharmacology Shared Resource has been an important component of the Cancer Center for many years. Development and evaluation of new agents for the treatment of malignant diseases has always been a high priority activity and area of emphasis within the Mayo Clinic Cancer Center. The purpose of the Pharmacology Shared Resource is to provide preclinical pharmacologic expertise, methodologies and support to cancer Center investigators. The Shared Resource also fosters integrated pharmacologic research in Center programs by providing expertise in methodologies uniquely available within this Shared Resource to Center investigators.

药理学共享资源多年来一直是癌症中心的重要组成部分。 开发和评估用于治疗恶性疾病的新药一直是马约诊所癌症中心的高度优先活动和重点领域。 药理学共享资源的目的是为癌症中心研究人员提供临床前药理学专业知识，方法和支持。 共享资源还通过向中心研究者提供该共享资源中唯一可用的方法学专业知识，促进中心项目中的综合药理学研究。